Cristina Bezzio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This study provides further support for the efficacy of this biosimilar, allowing for potential future reduction in costs for patients with IBD.

Cristina bezzioGastroenterology unitRho hospitalNorthern italyTurin hospitalAdalimumab biosimilarInflammatory bowelAmong biosimilarsInflammatory bowel disease